Tristan Peitz
Nessuna posizione attualmente
Storia della carriera di Tristan Peitz
Precedenti posizioni note di Tristan Peitz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| QSAM BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 01/05/2017 | 09/12/2020 |
| Independent Dir/Board Member | 01/05/2017 | 09/12/2020 | |
Cohen Capital Management, Inc. (California)
 Cohen Capital Management, Inc. (California) Investment ManagersFinance Cohen Capital Management, Inc. (CCM) is a registered independent wealth management firm headquartered in Corte Madera, California. The firm was founded by Jay A. Cohen in 1995. CCM manages clients’ cash balances, equity and fixed income portfolios on a fully disclosed basis primarily for high net-worth individuals. | Portfolio Manager-Fixed Income | 01/05/2010 | 01/07/2019 |
| Trading-Fixed Income | 01/05/2010 | 01/07/2019 |
Formazione di Tristan Peitz
| Stephen M. Ross School of Business | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Portfolio Manager-Fixed Income | 1 |
| Trading-Fixed Income | 1 |
| Director/Board Member | 1 |
Settori
| Finance | 2 |
| Process Industries | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Cohen Capital Management, Inc. (California)
Cohen Capital Management, Inc. (California) Investment ManagersFinance Cohen Capital Management, Inc. (CCM) is a registered independent wealth management firm headquartered in Corte Madera, California. The firm was founded by Jay A. Cohen in 1995. CCM manages clients’ cash balances, equity and fixed income portfolios on a fully disclosed basis primarily for high net-worth individuals. | Finance |
QSAM Biosciences, Inc.
 QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX. | Process Industries |
- Borsa valori
- Insiders
- Tristan Peitz
- Esperienza
